Delving into the Latest Updates on Mysun Pharma Co. Ltd. with Synapse

Overview

Basic Info

Introduction

Mysun Pharma Co. Ltd. is a privately-owned corporation based in Chifeng, China. The company specializes in the production of pharmaceutical goods.

Tags

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Top 5 Drug Type	Count

Small molecule drug	1

主要目的：本研究以赤峰蒙欣药业有限公司持证的阿昔洛韦片（规格：0.2g）为受试制剂，Glaxo Smithkline K.K.持证的阿昔洛韦片（商品名：Zovirax，规格：0.2g）为参比制剂，进行空腹/餐后状态下人体生物等效性试验，评价受试制剂和参比制剂在健康受试者体内的生物等效性。次要目的：观察受试制剂和参比制剂在健康受试者中的安全性。

[Translation]

Main purpose: This study used acyclovir tablets (specification: 0.2g) certified by Chifeng Mengxin Pharmaceutical Co., Ltd. as the test preparation and acyclovir tablets (trade name: Zovirax, specification: 0.2g) certified by Glaxo Smithkline K.K. as the reference preparation to conduct a human bioequivalence test under fasting/postprandial conditions to evaluate the bioequivalence of the test preparation and the reference preparation in healthy subjects. Secondary purpose: Observe the safety of the test preparation and the reference preparation in healthy subjects.

Start Date08 Jun 2022

Sponsor / Collaborator

Mysun Pharma Co. Ltd.

CTR20212986

/ CompletedNot Applicable

吲达帕胺片在健康受试者中随机、开放、两制剂、单次给药、双周期、双交叉空腹状态下的生物等效性试验

[Translation] A randomized, open-label, two-dose, single-dose, two-period, double-crossover bioequivalence study of indapamide tablets in healthy subjects under fasting conditions

主要目的：研究健康受试者空腹条件下单次口服由赤峰蒙欣药业有限公司生产的吲达帕胺片和LES LABORATOIRES SERVIER进口的吲达帕胺片的吸收速度和吸收程度，评价受试制剂与参比制剂的生物等效性。次要目的：观察受试制剂和参比制剂在健康受试者中的安全性。

[Translation]

Primary objective: To study the absorption rate and extent of a single oral administration of indapamide tablets produced by Chifeng Mengxin Pharmaceutical Co., Ltd. and imported by LES LABORATOIRES SERVIER to healthy subjects under fasting conditions, and to evaluate the bioequivalence of the test preparation and the reference preparation. Secondary objective: To observe the safety of the test preparation and the reference preparation in healthy subjects.

Start Date07 Sep 2021

Sponsor / Collaborator

Mysun Pharma Co. Ltd.

100 Clinical Results associated with Mysun Pharma Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Mysun Pharma Co. Ltd.

Login to view more data

100 Deals associated with Mysun Pharma Co. Ltd.

Login to view more data

100 Translational Medicine associated with Mysun Pharma Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data